These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 26698133)
1. The role of tandem stem cell transplantation for multiple myeloma patients. Martino M; Recchia AG; Fedele R; Neri S; Vincelli ID; Moscato T; Gentile M; Morabito F Expert Opin Biol Ther; 2016; 16(4):515-34. PubMed ID: 26698133 [TBL] [Abstract][Full Text] [Related]
2. First-line tandem high-dose chemotherapy and autologous stem cell transplantation versus single high-dose chemotherapy and autologous stem cell transplantation in multiple myeloma, a systematic review of controlled studies. Naumann-Winter F; Greb A; Borchmann P; Bohlius J; Engert A; Schnell R Cochrane Database Syst Rev; 2012 Oct; 10(10):CD004626. PubMed ID: 23076906 [TBL] [Abstract][Full Text] [Related]
3. Single versus tandem high-dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma: long-term results from the phase III GMMG-HD2 trial. Mai EK; Benner A; Bertsch U; Brossart P; Hänel A; Kunzmann V; Naumann R; Neben K; Egerer G; Ho AD; Hillengass J; Raab MS; Neubauer A; Peyn A; Ko YD; Peter N; Scheid C; Goldschmidt H Br J Haematol; 2016 Jun; 173(5):731-41. PubMed ID: 26990892 [TBL] [Abstract][Full Text] [Related]
4. Tandem Autologous Stem Cell Transplantation Does Not Benefit High-Risk Myeloma Patients in the Maintenance Era: Real-World Results from The Canadian Myeloma Research Group Database. Venner CP; Duggan P; Song K; Reece D; Sharma S; Su J; Jimenez-Zepeda VH; McCurdy A; Louzada M; Mian H; Sebag M; White D; Stakiw J; Kotb R; Aslam M; Reiman A; Gul E; Chu MP; Bergstrom D; LeBlanc R Transplant Cell Ther; 2024 Sep; 30(9):889-901. PubMed ID: 38971462 [TBL] [Abstract][Full Text] [Related]
5. The role of high-dose chemotherapy in the treatment of multiple myeloma: a controversy. Kyle RA Ann Oncol; 2000; 11 Suppl 1():55-8. PubMed ID: 10707780 [TBL] [Abstract][Full Text] [Related]
6. American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma. Giralt S; Garderet L; Durie B; Cook G; Gahrton G; Bruno B; Hari P; Lokhorst H; McCarthy P; Krishnan A; Sonneveld P; Goldschmidt H; Jagannath S; Barlogie B; Mateos M; Gimsing P; Sezer O; Mikhael J; Lu J; Dimopoulos M; Mazumder A; Palumbo A; Abonour R; Anderson K; Attal M; Blade J; Bird J; Cavo M; Comenzo R; de la Rubia J; Einsele H; Garcia-Sanz R; Hillengass J; Holstein S; Johnsen HE; Joshua D; Koehne G; Kumar S; Kyle R; Leleu X; Lonial S; Ludwig H; Nahi H; Nooka A; Orlowski R; Rajkumar V; Reiman A; Richardson P; Riva E; San Miguel J; Turreson I; Usmani S; Vesole D; Bensinger W; Qazilbash M; Efebera Y; Mohty M; Gasparreto C; Gajewski J; LeMaistre CF; Bredeson C; Moreau P; Pasquini M; Kroeger N; Stadtmauer E Biol Blood Marrow Transplant; 2015 Dec; 21(12):2039-2051. PubMed ID: 26428082 [TBL] [Abstract][Full Text] [Related]
8. Role of bone marrow transplantation in the disease pathway of myeloma. Harousseau JL; Moreau P J Natl Compr Canc Netw; 2007 Feb; 5(2):163-9. PubMed ID: 17335685 [TBL] [Abstract][Full Text] [Related]
9. Autologous stem cell transplantation in first remission is associated with better progression-free survival in multiple myeloma. Aggarwal M; Agrawal N; Yadav N; Verma P; Ahmed R; Mehta P; Kapoor J; Bhurani D Ann Hematol; 2018 Oct; 97(10):1869-1877. PubMed ID: 29781040 [TBL] [Abstract][Full Text] [Related]
10. [Stem cell transplantation in multiple myeloma]. Fukuda S; Sunami K; Sezaki T Gan To Kagaku Ryoho; 1999 Sep; 26(10):1407-14. PubMed ID: 10500527 [TBL] [Abstract][Full Text] [Related]
11. Sequential treatment with bortezomib plus dexamethasone followed by autologous hematopoietic stem cell transplantation in patients with multiple myeloma. Zheng D; Li J; Huang BH; Liu JR; Zou WY; Su C Chin Med J (Engl); 2012 Dec; 125(24):4454-9. PubMed ID: 23253719 [TBL] [Abstract][Full Text] [Related]
12. [Bortezomib-based induction therapy followed by autologous hematopoietic stem cell transplantation in multiple myeloma]. Huang B; Li J; Liu J; Gu J; Zheng D; Xu D; Zou W; Wang H Zhonghua Nei Ke Za Zhi; 2014 Nov; 53(11):865-72. PubMed ID: 25586356 [TBL] [Abstract][Full Text] [Related]
13. Treatment of multiple myeloma. San Miguel JF; Bladé Creixenti J; García-Sanz R Haematologica; 1999 Jan; 84(1):36-58. PubMed ID: 10091392 [TBL] [Abstract][Full Text] [Related]
14. Early or delayed transplantation for multiple myeloma in the era of novel therapy: does one size fit all? Richardson PG; Laubach JP; Munshi NC; Anderson KC Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):255-61. PubMed ID: 25696864 [TBL] [Abstract][Full Text] [Related]
15. Early Versus Delayed Autologous Stem Cell Transplantation and Interferon Maintenance in Multiple Myeloma: Single-Center Experience of 18 Years. Remenyi P; Varga G; Mikala G; Reti M; Gopcsa L; Batai A; Csukly Z; Lengyel L; Torbagyi E; Barta A; Fabian J; Levai D; Szombath G; Andrikovics H; Masszi T Transplant Proc; 2016; 48(1):177-84. PubMed ID: 26915865 [TBL] [Abstract][Full Text] [Related]
16. The role of high-dose melphalan and autologous stem cell transplant in the rapidly evolving era of modern multiple myeloma therapy. Voorhees PM; Usmani SZ Clin Adv Hematol Oncol; 2016 Sep; 14(9):719-28. PubMed ID: 27673290 [TBL] [Abstract][Full Text] [Related]
17. A phase II, single-arm, prospective study of bendamustine plus melphalan conditioning for second autologous stem cell transplantation in de novo multiple myeloma patients through a tandem transplant strategy. Martino M; Tripepi G; Messina G; Vincelli ID; Console G; Recchia AG; Gentile M; Molica S; Morabito F Bone Marrow Transplant; 2016 Sep; 51(9):1197-203. PubMed ID: 27088375 [TBL] [Abstract][Full Text] [Related]
19. Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement. Gonsalves WI; Buadi FK; Ailawadhi S; Bergsagel PL; Chanan Khan AA; Dingli D; Dispenzieri A; Fonseca R; Hayman SR; Kapoor P; Kourelis TV; Lacy MQ; Larsen JT; Muchtar E; Reeder CB; Sher T; Stewart AK; Warsame R; Go RS; Kyle RA; Leung N; Lin Y; Lust JA; Russell SJ; Zeldenrust SR; Fonder AL; Hwa YL; Hobbs MA; Mayo AA; Hogan WJ; Rajkumar SV; Kumar SK; Gertz MA; Roy V Bone Marrow Transplant; 2019 Mar; 54(3):353-367. PubMed ID: 29988062 [TBL] [Abstract][Full Text] [Related]
20. The role of transplant in multiple myeloma. Mei M; Somlo G J Natl Compr Canc Netw; 2014 Aug; 12(8):1131-8. PubMed ID: 25099445 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]